ClinicalTrials.Veeva

Menu

Study of the Effects of Probiotics Upon Infectious Episodes in Subject Aged More Than 60, During Winter.

Lallemand logo

Lallemand

Status

Completed

Conditions

Infectious Episodes (ENT, Gastro-intestinal and Pulmonary)

Treatments

Dietary Supplement: Starch of potato
Dietary Supplement: Lactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00796393
2008-A01187-48
10308

Details and patient eligibility

About

We put forward that probiotics have an effect on infectious episodes evolution in subjects aged 60 years or over. The main objective of this research is to observe the effect of consumption of the probiotic on the average number of days with infectious episodes.

Enrollment

200 patients

Sex

All

Ages

60 to 74 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects who accept not to alter their food habits

Exclusion criteria

  • Food allergy
  • Regular consumption of probiotics
  • Diabetes
  • Respiratory deficiency
  • Cardiac deficiency
  • Cancer or chronicle disease not stabilized
  • Splenectomy, sickle-cell anemia
  • Immuno depression or immunodeficiency acquired or congenital
  • Immuno depressor or corticoid treatments

Trial design

200 participants in 4 patient groups, including a placebo group

2
Experimental group
Description:
Subject with active product, not vaccinated against influenza.
Treatment:
Dietary Supplement: Lactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033
3
Placebo Comparator group
Description:
Subject with placebo, vaccinated against influenza.
Treatment:
Dietary Supplement: Starch of potato
4
Placebo Comparator group
Description:
Subject with placebo, not vaccinated against influenza.
Treatment:
Dietary Supplement: Starch of potato
1
Experimental group
Description:
Subject with active product, vaccinated against influenza
Treatment:
Dietary Supplement: Lactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems